Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Voltage-gated calcium channels in tapeworms are multisubunit transmembrane proteins that mediate the influx of Ca²⁺ in response to membrane depolarization, which is critical for neuromuscular activity and other calcium-dependent processes in the parasite. These channels are established therapeutic targets for anthelmintic agents, notably praziquantel, which induces calcium influx, sustained muscle contraction, paralysis, and parasite death. The channel structure includes a pore-forming alpha subunit and modulatory subunits, some of which are unique to platyhelminths and are under investigation for selective drug targeting. There is evidence of gene family diversity in these channels in tapeworms, with some subunit variants possibly playing a role in drug sensitivity.
Praziquantel increases permeability of the calcium channel, causing an influx of calcium ions (Ca²⁺), resulting in muscle contraction, paralysis, and eventual death of the parasite.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Voltage-gated calcium channel (tapeworm).